Department of Ophthalmology, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Biomedical Institute for Convergence (BICS), Sungkyunkwan University, Suwon, Korea.
Endocrinol Metab (Seoul). 2024 Jun;39(3):416-424. doi: 10.3803/EnM.2023.1913. Epub 2024 Jun 10.
Diabetic retinopathy (DR) is a major complication of diabetes mellitus and is a leading cause of vision loss globally. A prompt and accurate diagnosis is crucial for ensuring favorable visual outcomes, highlighting the need for increased access to medical care. The recent remarkable advancements in artificial intelligence (AI) have raised high expectations for its role in disease diagnosis and prognosis prediction across various medical fields. In addition to achieving high precision comparable to that of ophthalmologists, AI-based diagnosis of DR has the potential to improve medical accessibility, especially through telemedicine. In this review paper, we aim to examine the current role of AI in the diagnosis of DR and explore future directions.
糖尿病视网膜病变(DR)是糖尿病的主要并发症,也是全球视力丧失的主要原因。及时准确的诊断对于确保良好的视觉效果至关重要,这凸显了增加获得医疗保健的必要性。最近人工智能(AI)的显著进步,使其在各个医学领域的疾病诊断和预后预测中发挥作用的期望很高。除了达到与眼科医生相当的高精度外,基于 AI 的 DR 诊断还有望改善医疗的可及性,特别是通过远程医疗。在这篇综述论文中,我们旨在探讨 AI 在 DR 诊断中的当前作用,并探索未来的方向。